Cargando…
COVID-19 in patients with pre-existing chronic liver disease – predictors of outcomes
Coronavirus disease 2019 (COVID-19) has affected patients with pre-existing chronic liver disease (CLD) in various ways. The maximum impact was seen on patients with underlying cirrhosis who have shown to have poor clinical outcomes in the form of increased risk of hepatic decompensation, acute-on-c...
Autores principales: | Walia, Dinesh, Saraya, Anoop, Gunjan, Deepak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896592/ https://www.ncbi.nlm.nih.gov/pubmed/36743659 http://dx.doi.org/10.5501/wjv.v12.i1.30 |
Ejemplares similares
-
Vascular complications of chronic pancreatitis and its management
por: Walia, Dinesh, et al.
Publicado: (2023) -
Nutrition in acute pancreatitis
por: Gopi, Srikanth, et al.
Publicado: (2023) -
Outcomes of COVID-19 among patients with liver disease
por: Vujčić, Isidora
Publicado: (2023) -
Implications of metabolic dysfunction associated fatty liver disease in COVID-19
por: Chakraborty, Raja, et al.
Publicado: (2023) -
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases
por: Nayak, Baibaswata, et al.
Publicado: (2021)